Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/β-catenin signaling pathway.

Szczegóły
Abstrakt

Tytuł:: Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/β-catenin signaling pathway.
Autorzy:: Gu L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Li A; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Lin J; Department of Infection Disease, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Gan Y; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
He C; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Xiao R; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Liao J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Li Y; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. .
Guo S; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. .
Źródło:: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2022 Nov; Vol. 100 (11), pp. 1659-1670. Date of Electronic Publication: 2022 Oct 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: Berlin : Springer International
Original Publication: Berlin : Springer, c1994-
MeSH Terms:: SOX9 Transcription Factor*/genetics
SOX9 Transcription Factor*/metabolism
Trachea*/pathology
Wnt Signaling Pathway*
Animals ; Rats ; beta Catenin/genetics ; beta Catenin/metabolism ; Cell Proliferation/genetics ; Fibrosis ; Glycogen Synthase Kinase 3 beta/metabolism ; Inflammation/metabolism
References:: Oberg CL, Holden VK, Channick CL (2018) Benign central airway obstruction. Seminars in Respiratory and Critical Care Medicine 39:731–746. https://doi.org/10.1055/s-0038-1676574. (PMID: 10.1055/s-0038-167657430641591)
Freitas C, Martins N, Novais-Bastos H, Morais A, Fernandes G, Magalhaes A (2021) The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: a 20-year experience. Pulmonology 27:296–304. https://doi.org/10.1016/j.pulmoe.2019.12.004. (PMID: 10.1016/j.pulmoe.2019.12.00431901372)
Tata A, Kobayashi Y, Chow RD, Tran J, Desai A, Massri AJ, McCord TJ, Gunn MD, Tata PR (2018) Myoepithelial cells of submucosal glands can function as reserve stem cells to regenerate airways after injury. Cell Stem Cell 22(668–683):e666. https://doi.org/10.1016/j.stem.2018.03.018. (PMID: 10.1016/j.stem.2018.03.018)
Wang C, Tan Z, Niu B, Tsang KY, Tai A, Chan WCW, Lo RLK, Leung KKH, Dung NWF, Itoh N et al (2018) Inhibiting the integrated stress response pathway prevents aberrant chondrocyte differentiation thereby alleviating chondrodysplasia. eLife 7. https://doi.org/10.7554/eLife.37673.
Gajjala PR, Kasam RK, Soundararajan D, Sinner D, Huang SK, Jegga AG, Madala SK (2021) Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis. JCI Insight 6. https://doi.org/10.1172/jci.insight.152503.
Li XZ, Wang ZC, Qiu Y, Ma SX, Meng LB, Wu WH, Zhang P, Yang W, Song WP, Huang L (2020) Bioinformatics analysis and verification of gene targets for benign tracheal stenosis. Mol Genet Genomic Med 8:e1245. https://doi.org/10.1002/mgg3.1245. (PMID: 10.1002/mgg3.1245323099127284051)
Shahzad T, Irfan M (2016) Endobronchial tuberculosis-a review. J Thorac Dis 8:3797–3802. https://doi.org/10.21037/jtd.2016.12.73. (PMID: 10.21037/jtd.2016.12.73281495795227231)
Wang M, Liu Y, Li D, Xiong C, Qian X, Tang Y (2016) Endobronchial fibroma in a pneumoconiosis patient with a history of tuberculosis: a case report and literature review. Oncol Lett 12:1041–1045. https://doi.org/10.3892/ol.2016.4726. (PMID: 10.3892/ol.2016.4726274463914950651)
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262. (PMID: 10.1006/meth.2001.126211846609)
Fan Y, Li X, Fang X, Liu Y, Zhao S, Yu Z, Tang Y, Wu P (2021) Antifibrotic role of nintedanib in tracheal stenosis after a tracheal wound. Laryngoscope 131:E2496–E2505. https://doi.org/10.1002/lary.29618. (PMID: 10.1002/lary.2961834000066)
Fan XD, Zheng HB, Fan XS, Lu S (2018) Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-beta1. Biochem Biophys Res Commun 503:215–221. https://doi.org/10.1016/j.bbrc.2018.06.005. (PMID: 10.1016/j.bbrc.2018.06.00529879429)
Athwal VS, Pritchett J, Martin K, Llewellyn J, Scott J, Harvey E, Zaitoun AM, Mullan AF, Zeef LAH, Friedman SL et al (2018) SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Sci Rep 8:17905. https://doi.org/10.1038/s41598-018-36037-4. (PMID: 10.1038/s41598-018-36037-4305594596297163)
Athwal VS, Pritchett J, Llewellyn J, Martin K, Camacho E, Raza SM, Phythian-Adams A, Birchall LJ, Mullan AF, Su K et al (2017) SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. EMBO Mol Med 9:1696–1710. https://doi.org/10.15252/emmm.201707860. (PMID: 10.15252/emmm.201707860291091285709769)
Lacraz GPA, Junker JP, Gladka MM, Molenaar B, Scholman KT, Vigil-Garcia M, Versteeg D, de Ruiter H, Vermunt MW, Creyghton MP et al (2017) Tomo-Seq identifies SOX9 as a key regulator of cardiac fibrosis during ischemic injury. Circulation 136:1396–1409. https://doi.org/10.1161/CIRCULATIONAHA.117.027832. (PMID: 10.1161/CIRCULATIONAHA.117.02783228724751)
Bennett MR, Czech KA, Arend LJ, Witte DP, Devarajan P, Potter SS (2007) Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp Nephrol 107:e30-40. https://doi.org/10.1159/000106775. (PMID: 10.1159/00010677517684420)
Wang S, Li C, Yu Y, Qiao J (2019) Decreased expression of microRNA-145 promotes the biological functions of fibroblasts in hypertrophic scar tissues by upregulating the expression of transcription factor SOX-9. Exp Ther Med 18:3450–3460. https://doi.org/10.3892/etm.2019.7972. (PMID: 10.3892/etm.2019.7972316022206777315)
Scharf GM, Kilian K, Cordero J, Wang Y, Grund A, Hofmann M, Froese N, Wang X Kispert A, Kist R et al (2019) Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation. JCI Insight 5. https://doi.org/10.1172/jci.insight.126721.
Joshi S, De Angelis PM, Zucknick M, Schjolberg AR, Andersen SN, Clausen OPF (2020) Role of the Wnt signaling pathway in keratoacanthoma. Cancer Rep 3:e1219. https://doi.org/10.1002/cnr2.1219. (PMID: 10.1002/cnr2.121932672002)
Zhou G, Li C, Zhan Y, Zhang R, Lv B, Geng W, Zheng J (2020) Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/beta-catenin pathway. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 79:153321. https://doi.org/10.1016/j.phymed.2020.153321. (PMID: 10.1016/j.phymed.2020.153321)
Zhao H, Lu F, Cui S, Zhang X, Wang W, Si E, Yuan Z (2017) TMEM88 inhibits extracellular matrix expression in keloid fibroblasts. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 95:1436–1440. https://doi.org/10.1016/j.biopha.2017.09.047.
Timman ST, Schoemaker C, Li WWL, Marres HAM, Honings J, Morshuis WJ, van der Heijden E, Verhagen A (2018) Functional outcome after (laryngo)tracheal resection and reconstruction for acquired benign (laryngo)tracheal stenosis. Ann Cardiothorac Surg 7:227–236. https://doi.org/10.21037/acs.2018.03.07. (PMID: 10.21037/acs.2018.03.07297075005900076)
Ozdemir C, Kocaturk CI, Sokucu SN, Sezen BC, Kutluk AC, Bilen S, Dalar L (2018) Endoscopic and surgical treatment of benign tracheal stenosis: a multidisciplinary team approach. Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 24:288–295. https://doi.org/10.5761/atcs.oa.18-00073. (PMID: 10.5761/atcs.oa.18-00073)
Contributed Indexing:: Keywords: ECM; Granulation tissue hyperplasia; SOX9; Tracheal fibrosis; Wnt/β-catenin pathway
Substance Nomenclature:: 0 (beta Catenin)
EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta)
0 (SOX9 Transcription Factor)
0 (Sox9 protein, rat)
Entry Date(s):: Date Created: 20221003 Date Completed: 20221027 Latest Revision: 20221213
Update Code:: 20240105
DOI:: 10.1007/s00109-022-02261-9
PMID:: 36192639
: Czasopismo naukowe

Full Text Finder

Trachealfibrosis is an important cause of tracheal stenosis without effective treatments, and new drug targets need to be developed. The role of SOX9 in the injury and repair of the trachea is unknown; this study aims to investigate the role of SOX9 in the regulation of tracheal fibrosis based on clinical samples from patients with tracheal injury and a model of tracheal fibrosis produced by tracheal brushing in rats. The results showed that the expressions of SOX9 and mesenchymal and ECM-related indicators were increased in the injury and fibrosis of the trachea in patients and rats. Serum SOX9 levels exhibited a sensitivity of 83.87% and specificity of 90% in distinguishing patients with tracheal fibrosis from healthy volunteers when the cut‑off value was 13.24 ng/ml. Knockdown SOX9 can markedly inhibit granulation tissue proliferation, reduce inflammation and ECM deposition, promote epithelial regeneration and granulation tissue apoptosis, and attenuate the tracheal fibrosis after injury. Additionally, RNA sequencing showed that the proliferation, migration, and ECM deposition of tracheal granulation tissue were related to the activation of Wnt pathway, activation of the β-catenin, and p-GSK3β after injury can be inhibited by the knockdown of SOX9. In summary, SOX9 is upregulated in tracheas fibrosis and may be a novel factor to promote tracheal fibrosis progression. Inhibiting SOX9 may be used to prevent and treat tracheal fibrosis in the future. KEY MESSAGE : The expression of SOX9 is upregulated the process of injury and repair of the tracheal fibrosis. Knocking down SOX9 can attenuate tracheal fibrosis after injury by inhibiting inflammation response, granulation tissue proliferation, ECM deposition, and promoting granulation tissue apoptosis. The Wnt/β-catenin-SOX9 axis is activated during tracheal injury and fibrosis, and inhibition of SOX9 can partially alleviate tracheal fibrosis. SOX9 may act as a new diagnostic and therapeutic target in patients with tracheal fibrosis in the future.
(© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Informacja